Tiletamine, Zolazepam
267 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
267
Total Reports
77
Deaths Reported
2880.0%
Death Rate
Active Ingredients
Tiletamine, Zolazepam
Administration Routes
IntramuscularIntravenousUnknownSubcutaneousTopicalOtherOphthalmic
Species Affected
Dog 117
Cat 116
Unknown 25
Human 4
Other Deer 2
Other 2
Chimpanzee 1
Most Affected Breeds
Domestic (unspecified) 73
Cat (unknown) 35
Unknown 34
Dog (unknown) 32
Crossbred Canine/dog 13
Mixed (Dog) 9
Retriever - Labrador 8
Boxer (German Boxer) 5
Shepherd Dog - German 4
Pug 3
Most Reported Reactions
INEFFECTIVE, ANESTHESIA 51
Death 48
Cardiac arrest 30
Apnoea 28
Death by euthanasia 25
Fever 24
Vomiting 21
Vocalisation 20
Depression 19
Solution, Abnormal 19
Anorexia 18
Hyperexcitation 13
Outcome Breakdown
Died
75 (89.3%)
Recovered/Normal
5 (6.0%)
Euthanized
2 (2.4%)
Outcome Unknown
1 (1.2%)
Ongoing
1 (1.2%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.